Berkley and Jensen Triple Antibiotic (BJWC)
Welcome to the PulseAid listing for the Berkley and Jensen Triple Antibiotic drug offered from BJWC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | BJWC |
NON-PROPRIETARY NAME: | bacitracin, neomycin salfate, polymyxin B sulfate |
SUBSTANCE NAME: | BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | OINTMENT |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2008-12-16 |
END MARKETING DATE: | 0000-00-00 |
Berkley and Jensen Triple Antibiotic HUMAN OTC DRUG Details:
Item Description | Berkley and Jensen Triple Antibiotic from BJWC |
LABELER NAME: | BJWC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400; 3.5; 5000([USP’U]/g; mg/g; [USP’U]/g) |
START MARKETING DATE: | 2008-12-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68391-067_cec26aab-cd87-4c4c-b3f5-6a956aeb9de3 |
PRODUCT NDC: | 68391-067 |
APPLICATION NUMBER: | part333B |
Other BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers: